Participants 121 408 9
unicenter, single-blind, randomized study was conducted on 283 patients with active duodenal ulcer to compare possible factors that may affect healing and relapse in patients treated with a potent antisecretory agent, cimetidine, or a site-protective and cytoprotective agent, sucralfate
Participants 1166 1242 3
the patients with healed ulcers, 238 participated in a 24-mo follow-up study
